The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

The new funding will enable the company to enhance its AI-powered platform, strengthen its technology infrastructure, and expand into new international markets, including high-growth regions across ...

This investment will fuel Spyne's growth trajectory, focusing on aggressive expansion in the US and developing its ...

Spyne, an AI-powered visual merchandising platform for the automotive industry, has raised $16 million in a Series A funding ...

Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...

Eli Lilly should easily beat the market again in 2025, as it did in 2024. Summit Therapeutics awaits a potentially huge ...

Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options ...

Indian startups collectively secured approximately $375.52 million in funding, comprising 7 grow th-stage deals and 22 ...

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

The Viper red dot and mount are made from a single piece of 6061 aluminum and fits directly onto the receiver of most ...